Zelira Therapeutics Limited (ZLD.AX)
ASX - ASX Delayed price. Currency in AUD
Add to watchlist
At close: 04:10PM AEST
| Previous close | 1.3800 |
| Open | 1.3800 |
| Bid | 1.5000 x 14831600 |
| Ask | 1.6300 x 5161300 |
| Day's range | 1.3800 - 1.6300 |
| 52-week range | 1.1750 - 9.4505 |
| Volume | |
| Avg. volume | 7,358 |
| Market cap | 15.611M |
| Beta (5Y monthly) | 1.12 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.5050 |
| Earnings date | 23 Feb 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 13.03 |
- Simply Wall St.
Zelira Therapeutics (ASX:ZLD) Will Have To Spend Its Cash Wisely
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
- PR Newswire
Zelira™ Launches RAF FIVE™ Acne Treatment Products Through Its Dermatology Focused Subsidiary
Zelira Therapeutics Ltd (ASX: ZLD) (OTCQB: ZLDAF), a global leader in the research and development of clinically validated cannabinoid medicines, is pleased to announce the US launch of the Zelira Dermatology Business' first product line, RAF FIVE™, through its dermatology subsidiary Ilera Derm LLC ("Zelira Dermatology").
- Simply Wall St.
We Think Zelira Therapeutics (ASX:ZLD) Needs To Drive Business Growth Carefully
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
© 2022 Yahoo. All rights reserved.
